Ibogaine has a reputation as the heavyweight of psychedelic addiction interruption. One dose, and opioid withdrawal reportedly collapses in on itself. Long-term users describe walking out of a clinic with cravings that had ruled them for a decade suddenly quiet. That's the story you'll find on most retreat websites, and for a meaningful number of people, it's true.

What you won't find on those same websites, at least not in the headline copy, is a candid discussion of what happens when ibogaine goes sideways psychologically. Not the cardiac risks — those get talked about, mostly because people have died and the medical literature forced the conversation. I'm talking about the psychiatric aftermath. The prolonged confusion, the depersonalisation that won't lift, the psychotic episodes that show up weeks after the flood dose is technically out of the system.

If you're researching an ibogaine retreat for addiction, trauma, or a stuck depressive pattern, this is the conversation you deserve to have before you hand over the deposit.

What ibogaine actually does — a short, honest version

Ibogaine is the primary alkaloid in the root bark of Tabernanthe iboga, a shrub used ceremonially for centuries by the Bwiti of Gabon and neighbouring communities. In the West, it's used almost exclusively at flood doses to interrupt opioid, stimulant, and alcohol dependence. A flood dose typically runs 12 to 36 hours — a long, physically demanding waking dream state where autobiographical memories arrive with unusual clarity and the nervous system takes a genuine beating.

The mechanism is messy. Ibogaine hits serotonin transporters, NMDA receptors, sigma sites, kappa and mu opioid receptors, and nicotinic receptors. It also metabolises into noribogaine, which lingers in the body for weeks and does its own quieter work on mood and craving. That long tail is part of why ibogaine seems to work for addiction — and part of why the psychiatric risks can show up long after you've flown home.

So when people ask me whether ibogaine is a psychedelic or a medication or something else, my honest answer is: it's its own thing. Comparing it to ayahuasca or psilocybin misses the point. It behaves more like a pharmacological demolition crew than a plant medicine facilitator.

Can ibogaine trigger psychosis? What the reports actually say

Yes. It's rare, but it happens, and if it happens to you, rare doesn't matter.

Case reports in the medical literature and firsthand accounts from harm-reduction forums describe a spectrum of post-ibogaine psychiatric events: prolonged dissociation lasting weeks, manic episodes, paranoid ideation that outlives the acute experience, and full psychotic breaks requiring hospitalisation. Some resolve on their own with time and stability. Others require antipsychotic medication and long-term psychiatric follow-up. A handful become chronic.

The population most at risk is fairly consistent across reports:

• People with a personal or family history of schizophrenia, schizoaffective disorder, or bipolar I
• People currently in stimulant-induced psychosis or coming off long stimulant runs
• People with untreated or poorly managed complex PTSD who dissociate heavily under stress
• People taking SSRIs, MAOIs, or antipsychotics who don't disclose it or aren't properly tapered
• People combining ibogaine with other psychedelics in the days before or after

A responsible clinic screens for all of this. A cash-in-hand operation in a jurisdiction with no oversight may not. That distinction matters more than almost any other factor in your decision.

Why the psychiatric risk gets downplayed

Two reasons, and they're both worth naming.

First, ibogaine treatment exists in a strange legal grey zone. It's a Schedule I substance in the United States, unscheduled in Mexico, Costa Rica, Portugal, New Zealand, South Africa, and a handful of other countries. Clinics operate outside the regulatory frameworks that would normally require adverse-event reporting. When something goes wrong, there's no central registry. The clinic knows. The family knows. The wider community sometimes hears through Reddit or word of mouth, months later.

Second, the people drawn to ibogaine are often at the end of their rope. Someone facing another fentanyl relapse or a decade of failed rehabs isn't in a great headspace to weigh a five-percent risk of prolonged psychiatric complications against the near-certainty of continued use. And the clinics know this. The marketing skews toward hope, because hope is what sells, and because in fairness, hope is often warranted.

But hope without informed consent isn't medicine. It's marketing.

Questions to ask any ibogaine clinic before you commit

If you're seriously considering this, here's the shortlist I'd walk in with. If the clinic can't answer these clearly, that's your answer.

1. Who does your medical screening, and what's in it? A proper workup includes an EKG, liver panel, electrolytes, and a thorough psychiatric history. If they screen by intake form only, walk away.
2. Is a physician on-site for the entire flood dose? Not a nurse checking in. A doctor, present, for the full duration.
3. What's your protocol if someone develops acute psychiatric symptoms during or after? They should have a named receiving hospital, a transport plan, and a psychiatrist on call.
4. How long is aftercare, and what does it include? A three-day flood dose followed by a taxi to the airport is not treatment. It's an experience.
5. What's your policy on antidepressants and antipsychotics? There should be a supervised taper protocol, not a "just stop taking them a week before" email.
6. How many treatments have you done, and how many adverse events? An honest clinic gives you numbers. A dishonest one gives you testimonials.

What integration looks like — and why it matters more with ibogaine

With ayahuasca or psilocybin, integration is the work of translating insight into changed behaviour. With ibogaine, integration is also nervous-system repair. The flood dose leaves people physically flattened for weeks. Sleep gets weird. Emotions come in unpredictable waves. The noribogaine tail keeps altering perception long after you feel like the experience is over.

Good integration after ibogaine looks like this: a stable, low-stimulation environment for at least two to four weeks post-treatment; regular contact with a therapist who understands psychedelic aftercare (this is a small field — ask specifically); no alcohol, no cannabis, no other psychedelics for a minimum of a month, ideally longer; sleep hygiene taken seriously; and a plan for what happens when the honeymoon window closes and cravings, if they return, meet a person with different tools than before.

Skipping this stage is where a lot of the "ibogaine didn't work for me" stories actually come from. The molecule opened a door. Nobody helped the person walk through it.

Is ibogaine right for you? An honest gut-check

I've watched ibogaine change lives. I've also watched it derail people who weren't ready. Here's the rough frame I'd offer:

Ibogaine may be worth the risk profile if you have opioid dependence that hasn't responded to conventional treatment, no personal or first-degree family history of psychotic disorders, a clean cardiac workup, a support system you can lean on for a month afterwards, and the means to attend a clinic with real medical infrastructure rather than the cheapest option you can find.

Ibogaine is probably not the right first move if you're primarily looking for insight rather than addiction interruption, if you have a mood or thought disorder in your family tree, if you're currently on psychiatric medication you'd have to stop suddenly, or if the retreat you can afford operates without medical oversight. In those cases, gentler plant medicines — ayahuasca in a well-run traditional setting, psilocybin, San Pedro — carry meaningfully lower psychiatric risk and may still deliver the shift you're hoping for.

None of this is meant to scare you off. It's meant to make sure that if you do go, you go with your eyes open, to a place that deserves your trust, with a plan for what happens when you come home.

For readers who want to compare vetted programs across the plant-medicine space — including ibogaine clinics that publish their protocols openly — a curated selection of retreats can be browsed on our marketplace here. Take your time with the decision. The right retreat is the one you don't have to talk yourself into.